ExpertAsia-improving patient outcomes - Introducing PCDx - targeted diagnostics for oncology patients
PCDx: Best in Class NGS assay on FFPE

  • Fast Turnaround: Clinical report delivered in 4 to 5 business days to ensure continuity of clinical care.

  • High Confidence: Average depth of coverage is >5,000x to ensure accuracy of NGS call

  • Comprehensive:  PCDx analysis includes next generation sequencing (NGS) for mutations, gene fusions, copy number variations, mRNA expression and optional IHC for protein pathways & immune-checkpoint  analysis to ensure the most comprehensive look at the patient’s genomic/proteomic/immnunologic landscape.
Website Builder provided by  Vistaprint